It does product testing which could be considered boring but is also necessary and has its place. There are two themes: on-shoring and outsourcing. With more products being made in the US because of on-shoring there is more demand for testing of these products so we should continue to see growth. Nobody has been really looking at it so that could be of benefit. Buy 7 Hold 4 Sell 1
They just reported great numbers, top and bottom line beats with outperformance in all 3 businesses. Is up more than 80% since they went public in April.
Up 50% since the IPO 6 weeks ago. It just reported a strong first quarter. Not overheated. He likes their story of testing products for customers in the safety science services segment.
It does product testing which could be considered boring but is also necessary and has its place. There are two themes: on-shoring and outsourcing. With more products being made in the US because of on-shoring there is more demand for testing of these products so we should continue to see growth. Nobody has been really looking at it so that could be of benefit. Buy 7 Hold 4 Sell 1
(Analysts’ price target is $71.19)